Reducing Prescription Opioid Misuse: ROPEs Pilot Trial
| Tracking Information | |||
|---|---|---|---|
| First Submitted Date ICMJE | September 27, 2018 | ||
| First Posted Date ICMJE | October 2, 2018 | ||
| Last Update Posted Date | October 4, 2018 | ||
| Actual Study Start Date ICMJE | January 2019 | ||
| Estimated Primary Completion Date | August 2019 (Final data collection date for primary outcome measure) | ||
| Current Primary Outcome Measures ICMJE |
Methodological Feasibility: Recruitment Rate[ Time Frame: Baseline completion, approximately 2 hours ] Number of Participants Recruited Methodological Feasibility: Completion Rates[ Time Frame: Baseline completion, approximately 2 hours ] Percent of Patients Completing ROPES (or control) Methodological Feasibility: Follow-Up Completion Rates[ Time Frame: Through study completion, an average of 4-6 weeks (Baseline and one-month follow-up) ] Percent of baseline participants completing the one-month follow-up assessment Methodological Feasibility: Time to Complete Intervention[ Time Frame: Baseline completion component, approximately 90 minutes ] Time participant takes to finish engaging with ROPES intervention or control intervention |
||
| Original Primary Outcome Measures ICMJE | Same as current | ||
| Current Secondary Outcome Measures ICMJE |
|
||
| Descriptive Information | |||
| Brief Title ICMJE | Reducing Prescription Opioid Misuse: ROPEs Pilot Trial |
||
| Official Title ICMJE | Reducing Prescription Opioid Misuse: Dental Provider Intervention Development |
||
| Brief Summary | This is a randomized controlled pilot trial to establish methodological feasibility and determine whether a web-based, continuing dental education intervention regarding opioid prescribing risk mitigation strategies - consistent with ADA guidelines - produces pre-to-post changes in knowledge, motivation, and behavioral skills pertaining to the use of risk mitigation strategies when prescribing opioids in dental practice. The current study involves completion of a self-report pre-test (dentists), randomization to complete ROPEs or attention control intervention, completion of a self-report post-test (immediately following intervention/control completion), and completion of 1-month self-report follow-up assessment. |
||
| Detailed Description | |||
| Study Type ICMJE | Interventional | ||
| Study Phase | N/A | ||
| Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Intervention Model Description: Masking: Interventional Masking Description: Primary Purpose: Other |
||
| Condition ICMJE | |||
| Intervention ICMJE |
|
||
| Study Arms |
|
||
| Recruitment Information | |||
| Recruitment Status ICMJE | Not yet recruiting | ||
| Estimated Enrollment ICMJE |
60 | ||
| Original Estimated Enrollment ICMJE | Same as current | ||
| Estimated Study Completion Date | August 2019 | ||
| Estimated Primary Completion Date | August 2019 (Final data collection date for primary outcome measure) | ||
| Eligibility Criteria ICMJE | Inclusion Criteria: 1. Male or female; any race or ethnicity; age 21-85 years. 2. Able to comprehend English. 3. Be either a licensed dental practitioner currently practicing or a Resident enrolled in the College of Dental Medicine at the Medical University of South Carolina or a practicing dentist in the Charleston-county area or a licensed dental practitioner currently participating in the National Dental Practice Based Research Network (NDPBRN). 4. Report having ever prescribed an opioid analgesic to a patient 5. Must have Internet access 6. Must have a valid, usable email account 7. Must agree to complete all study measurements. Exclusion Criteria: 1. Unable to provide informed consent due to mental or physical limitations. 2. Participation in ROPEs intervention development focus groups. | ||
| Sex/Gender |
|
||
| Ages | 18 Years and older (Adult, Older Adult) | ||
| Accepts Healthy Volunteers | No | ||
| Listed Location Countries ICMJE | |||
| Removed Location Countries | |||
| Administrative Information | Has Data Monitoring Committee | Yes | |
| U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
| IPD Sharing Statement |
|
||
| Responsible Party | Jenna McCauley,Medical University of South Carolina | ||
| Study Sponsor ICMJE | Medical University of South Carolina | ||
| Collaborators ICMJE | |||
| Investigators ICMJE |
|
||
| PRS Account | Medical University of South Carolina | ||
| Verification Date | October 2018 | ||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||

